PAH and phenylketonuria: Our studies identified the highest prevalence of phenylketonuria around the world (birth prevalence 1:850 newborns) in one region of the Russian Federation, and it is associated with the spread of a specific mutation (p.R261∗ in the PAH gene) associated with the founder effect (Gundorova et al., 2018).